Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) FCF Margin (2020 - 2025)

Bioventus' FCF Margin history spans 6 years, with the latest figure at 25.15% for Q4 2025.

  • For Q4 2025, FCF Margin rose 1315.0% year-over-year to 25.15%; the TTM value through Dec 2025 reached 13.1%, up 651.0%, while the annual FY2025 figure was 13.1%, 651.0% up from the prior year.
  • FCF Margin reached 25.15% in Q4 2025 per BVS's latest filing, up from 21.37% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 25.15% in Q4 2025 to a low of 22.25% in Q2 2021.
  • Average FCF Margin over 5 years is 4.04%, with a median of 6.83% recorded in 2021.
  • Peak YoY movement for FCF Margin: crashed -4437bps in 2021, then soared 1757bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 13.03% in 2021, then tumbled by -63bps to 4.84% in 2022, then soared by 112bps to 10.25% in 2023, then increased by 17bps to 11.99% in 2024, then skyrocketed by 110bps to 25.15% in 2025.
  • Per Business Quant, the three most recent readings for BVS's FCF Margin are 25.15% (Q4 2025), 21.37% (Q3 2025), and 17.1% (Q2 2025).